{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T04:05:35Z","timestamp":1781409935934,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003447","name":"State Scholarships Foundation","doi-asserted-by":"publisher","award":["5001552"],"award-info":[{"award-number":["5001552"]}],"id":[{"id":"10.13039\/501100003447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Brucellosis, caused by several <jats:italic>Brucella<\/jats:italic> species, such as the bacterium <jats:italic>Brucella melitensis<\/jats:italic>, is considered one of the most severe zoonotic diseases worldwide. Not only does it affect ruminant animal populations, leading to a substantial financial burden for stockbreeders, but also poses severe public health issues. For almost four decades in southern Europe and elsewhere, eradication of the disease has been based on ambiguously effective programs, rendering massive sanitation of livestock urgent and indispensable. Gene therapy, which has been proved effective in the clinic, could possibly constitute an alternative option towards a permanent cure for brucellosis, by aiding in the deletion or inactivation of genes associated with the replication of <jats:italic>Brucella<\/jats:italic> within the host cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We infected ovine macrophages with <jats:italic>B.melitensis<\/jats:italic>, to simulate the host cell\/microorganism interaction in vitro, and transduced the infected cells with CRISPR\/Cas9 lentiviral vectors that target <jats:italic>Brucella<\/jats:italic>\u2019s RNA polymerase subunit A (RpolA) or virulence-associated gene <jats:italic>virB10<\/jats:italic> at a multiplicity of infection of 60. We demonstrate a significant decrease in the bacterial load per cell when infected cells are transduced with the RpolA vector and that the number of internalized brucellae per cell remains unaffected when macrophages are transduced with a conventional lentiviral vector expressing the green fluorescence protein, thus underlining the bactericidal effect of our CRISPR\/Cas9 system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pending in vivo verification of our findings, overall, these results may prove critical not only for the treatment of human brucellosis, but for other infectious diseases in general.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-019-2179-z","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T05:02:54Z","timestamp":1574830974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a CRISPR\/Cas9 system against ruminant animal brucellosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Garyfalia","family":"Karponi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon K.","family":"Kritas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet-Kalliopi","family":"Akrioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Petridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"3","key":"2179_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1574-6976.2012.00334.x","volume":"36","author":"K von Bargen","year":"2012","unstructured":"von Bargen K, Gorvel JP, Salcedo SP. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev. 2012;36(3):533\u201362.","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"2179_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059751","volume":"8","author":"G Gomez","year":"2013","unstructured":"Gomez G, Pei J, Mwangi W, Adams LG, Rice-Ficht A, Ficht TA. Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approach. PLoS One. 2013;8(3):e59751.","journal-title":"PLoS One"},{"issue":"1","key":"2179_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.20506\/rst.32.1.2187","volume":"32","author":"AE D\u00edaz","year":"2013","unstructured":"D\u00edaz AE. Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus. Rev Sci Tech. 2013;32(1):53\u201360.","journal-title":"Rev Sci Tech"},{"issue":"4","key":"2179_CR4","first-page":"315","volume":"19","author":"JC Wallach","year":"1997","unstructured":"Wallach JC, Samartino LE, Efron A, Baldi PC. Human infection by Brucella melitensis: an outbreak attributed to contact with infected goats. FEMS Immunol Med Microbiol. 1997;19(4):315\u201321.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"2179_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1365-2672.2005.02622.x","volume":"98","author":"SJ Cutler","year":"2005","unstructured":"Cutler SJ, Whatmore AM, Commander NJ. Brucellosis - new aspects of an old disease. J Appl Microbiol. 2005;98(6):1270\u201381.","journal-title":"J Appl Microbiol"},{"issue":"1\u20134","key":"2179_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0378-1135(02)00235-3","volume":"90","author":"LG Adams","year":"2002","unstructured":"Adams LG. The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Vet Microbiol. 2002;90(1\u20134):553\u201361.","journal-title":"Vet Microbiol"},{"key":"2179_CR7","doi-asserted-by":"publisher","first-page":"743509","DOI":"10.1155\/2013\/743509","volume":"2013","author":"ED Avila-Calder\u00f3n","year":"2013","unstructured":"Avila-Calder\u00f3n ED, Lopez-Merino A, Sriranganathan N, Boyle SM, Contreras-Rodr\u00edguez A. A history of the development of Brucella vaccines. Biomed Res Int. 2013;2013:743509.","journal-title":"Biomed Res Int"},{"key":"2179_CR8","doi-asserted-by":"publisher","first-page":"e0185823","DOI":"10.1371\/journal.pone.0185823","volume":"12","author":"JL Higgins","year":"2017","unstructured":"Higgins JL, Bowen RA, Gonzalez-Juarrero M. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1. PLoS One. 2017;12:e0185823.","journal-title":"PLoS One"},{"issue":"3\u20134","key":"2179_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","volume":"31","author":"JM Blasco","year":"1997","unstructured":"Blasco JM. A review of the use of B. melitensis rev 1 vaccine in adult sheep and goats. Prev Vet Med. 1997;31(3\u20134):275\u201383.","journal-title":"Prev Vet Med"},{"issue":"1","key":"2179_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.prevetmed.2004.03.007","volume":"64","author":"A Minas","year":"2004","unstructured":"Minas A, Minas M, Stournara A, Tselepidis S. The \u201ceffects\u201d of rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med. 2004;64(1):41\u20137.","journal-title":"Prev Vet Med."},{"issue":"1\u20134","key":"2179_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0378-1135(02)00231-6","volume":"90","author":"M Banai","year":"2002","unstructured":"Banai M. Control of small ruminant brucellosis by use of Brucella melitensis rev.1 vaccine: laboratory aspects and field observations. Vet Microbiol. 2002;90(1\u20134):497\u2013519.","journal-title":"Vet Microbiol"},{"issue":"2","key":"2179_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","volume":"6","author":"G Pappas","year":"2006","unstructured":"Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2179_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3325\/cmj.2010.51.283","volume":"51","author":"DM Donev","year":"2010","unstructured":"Donev DM. Brucellosis as priority public health challenge in south eastern European countries. Croat Med J. 2010;51(4):283\u20134.","journal-title":"Croat Med J"},{"issue":"4","key":"2179_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2174\/1573406413666170209122131","volume":"13","author":"G Karponi","year":"2017","unstructured":"Karponi G, Zogas N, Domvri K, Zarogoulidis P, Trakada G, Roumeliotis S, et al. Prospects of gene therapy for pulmonary diseases: progress and limitations. Med Chem. 2017;13(4):308\u201318.","journal-title":"Med Chem"},{"issue":"5466","key":"2179_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint BG, Gross F, Yvon E, Nusbaum P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669\u201372.","journal-title":"Science"},{"issue":"5","key":"2179_CR16","first-page":"447","volume":"360","author":"A Aiuti","year":"2009","unstructured":"Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. Science. 2009;360(5):447\u201358.","journal-title":"Science"},{"issue":"5954","key":"2179_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326(5954):818\u201323.","journal-title":"Science"},{"issue":"6148","key":"2179_CR18","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341(6148):1233158.","journal-title":"Science"},{"issue":"6148","key":"2179_CR19","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013;341(6148):1233151.","journal-title":"Science"},{"issue":"2","key":"2179_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/hum.2016.007","volume":"27","author":"O Negre","year":"2016","unstructured":"Negre O, Eggimann A-V, Beuzard Y, Ribeil J-A, Bourget P, Borwornpinyo S, et al. Gene therapy of the \u03b2-hemoglobinopathies by lentiviral transfer of the \u03b2(a(T87Q))-globin gene. Hum Gene Ther. 2016;27(2):148\u201365.","journal-title":"Hum Gene Ther"},{"issue":"5","key":"2179_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/hgtb.2018.032","volume":"29","author":"G Karponi","year":"2018","unstructured":"Karponi G, Papayanni PG, Zervou F, Bouinta A, Anagnostopoulos A, Yannaki E. The functional effect of repeated cryopreservation on transduced CD34+ cells from patients with thalassemia. Hum Gene Ther Methods. 2018;29(5):220\u20137.","journal-title":"Hum Gene Ther Methods"},{"key":"2179_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/TACG.S178546","volume":"12","author":"G Karponi","year":"2019","unstructured":"Karponi G, Zogas N. Gene therapy for beta-thalassemia: updated perspectives. Appl Clin Genet. 2019;12:167\u201380.","journal-title":"Appl Clin Genet"},{"key":"2179_CR23","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/ncomms7267","volume":"6","author":"E Choudhary","year":"2015","unstructured":"Choudhary E, Thakur P, Pareek M, Agarwal N. Gene silencing by CRISPR interference in mycobacteria. Nat Commun. 2015;6:6267.","journal-title":"Nat Commun"},{"issue":"18","key":"2179_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw625","volume":"44","author":"AK Singh","year":"2016","unstructured":"Singh AK, Carette X, Potluri LP, Sharp JD, Xu R, Prisic S, et al. Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. Nucleic Acids Res. 2016;44(18):e143.","journal-title":"Nucleic Acids Res"},{"key":"2179_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.38","volume":"3","author":"SR Lin","year":"2014","unstructured":"Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, et al. The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids. 2014;3:e186.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"31","key":"2179_CR26","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"W Hu","year":"2014","unstructured":"Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, et al. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci. 2014;111(31):11461\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"2179_CR27","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.1422340112","volume":"112","author":"AA Price","year":"2015","unstructured":"Price AA, Sampson TR, Ratner HK, Grakoui A, Weiss DS. Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci. 2015;112(19):6164\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"2179_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen FR, Kruse EM, Hooykaas MJG, Bruggeling CE, Sch\u00fcrch AC, van Ham PM, et al. CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathog. 2016;12(6):e1005701.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2179_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/vetsci5020057","volume":"5","author":"G Karponi","year":"2018","unstructured":"Karponi G, Kritas S, Petridou E, Papanikolaou E. Efficient transduction and expansion of ovine macrophages for gene therapy implementations. Vet Sci. 2018;5(2):57.","journal-title":"Vet Sci"},{"issue":"3","key":"2179_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/vetsci6030071","volume":"6","author":"G Karponi","year":"2019","unstructured":"Karponi G, Kritas SK, Papanikolaou E, Petridou E. A cellular model of infection with Brucella melitensis in ovine macrophages: novel insights for intracellular bacterial detection. Vet Sci. 2019;6(3):71.","journal-title":"Vet Sci"},{"issue":"7504","key":"2179_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature13420","volume":"510","author":"P Genovese","year":"2014","unstructured":"Genovese P, Schiroli G, Escobar G, Di Tomaso T, Firrito C, Calabria A, et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature. 2014;510(7504):235\u201340.","journal-title":"Nature"},{"issue":"11","key":"2179_CR32","first-page":"3448","volume":"22","author":"MA Bakhrebah","year":"2018","unstructured":"Bakhrebah MA, Nassar MS, Alsuabeyl MS, Zaher WA, Meo SA. CRISPR technology: new paradigm to target the infectious disease pathogens. Eur Rev Med Pharmacol Sci. 2018;22(11):3448\u201352.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2179_CR33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/IAI.61.1.124-134.1993","volume":"61","author":"X Jiang","year":"1993","unstructured":"Jiang X, Baldwin CL. Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun. 1993;61(1):124\u201334.","journal-title":"Infect Immun"},{"key":"2179_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcimb.2015.00072","volume":"5","author":"Y Ke","year":"2015","unstructured":"Ke Y, Wang Y, Li W, Chen Z. Type IV secretion system of Brucella spp and its effectors. Front Cell Infect Microbiol. 2015;5:72.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2179_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/hum.2011.048","volume":"23","author":"E Papanikolaou","year":"2012","unstructured":"Papanikolaou E, Georgomanoli M, Stamateris E, Panetsos F, Karagiorga M, Tsaftaridis P, et al. The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells. Hum Gene Ther. 2012;23(1):15\u201331.","journal-title":"Hum Gene Ther"},{"issue":"6166","key":"2179_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343(6166):84\u20137.","journal-title":"Science"},{"issue":"1","key":"2179_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2013.03.015","volume":"175","author":"E Papanikolaou","year":"2013","unstructured":"Papanikolaou E, Kontostathi G, Drakopoulou E, Georgomanoli M, Stamateris E, Vougas K, et al. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation. Virus Res. 2013;175(1):1\u201311.","journal-title":"Virus Res"},{"issue":"24","key":"2179_CR38","doi-asserted-by":"publisher","first-page":"15711","DOI":"10.1073\/pnas.232454299","volume":"99","author":"S Kohler","year":"2002","unstructured":"Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, et al. The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc Natl Acad Sci. 2002;99(24):15711\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"2179_CR39","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.1128\/IAI.71.12.7053-7060.2003","volume":"71","author":"P Lestrate","year":"2003","unstructured":"Lestrate P, Dricot A, Delrue RM, Lambert C, Martinelli V, De Bolle X, et al. Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice. Infect Immun. 2003;71(12):7053\u201360.","journal-title":"Infect Immun"},{"issue":"5","key":"2179_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2015-03-629618","volume":"126","author":"G Karponi","year":"2015","unstructured":"Karponi G, Psatha N, Lederer CW, Adair JE, Zervou F, Zogas N, et al. Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy. Blood. 2015;126(5):616\u20139.","journal-title":"Blood"},{"issue":"10","key":"2179_CR41","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1101\/gr.8.10.1022","volume":"8","author":"IY Lee","year":"1998","unstructured":"Lee IY, Westaway D, Smit AFA, Wang K, Seto J, Chen L, et al. Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res. 1998;8(10):1022\u201337.","journal-title":"Genome Res"},{"key":"2179_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1746-6148-1-3","volume":"1","author":"D Garcia-Crespo","year":"2005","unstructured":"Garcia-Crespo D, Juste RA, Hurtado A. Selection of ovine housekeeping genes for normalisation by real-time RT-PCR; analysis of PrP gene expression and genetic susceptibility to scrapie. BMC Vet Res. 2005;1:3.","journal-title":"BMC Vet Res"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2179-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-2179-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2179-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T01:01:13Z","timestamp":1606352473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-2179-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-2179-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to Greek National Legislation (Presidential Degree 56\/2013), authorization from the institutional review board (IRB) to implement basic research protocols as the one described in the current paper is not required. Regarding the consent from the owner, based on the above legislation it is not mandatory to obtain written consent to work with sheep blood from the owners, so we obtained an oral one. The blood sample was drawn during routine testing of the animals and no animal was ad hoc subjected to blood collection. No animal was subjected to any pain, discomfort or distressed during handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}